Sung, H., J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, and F. Bray (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3). https://https://doi.org/10.3322/caac.21660

Siegel, R.L., K.D. Miller, S.A. Fedewa, D.J. Ahnen, R.G.S. Meester, A. Barzi, and A. Jemal (2017) Colorectal cancer statistics, 2017. CA Cancer J Clin 67(3). https://https://doi.org/10.3322/caac.21395

Valentini, V., C. Aristei, B. Glimelius, B.D. Minsky, R. Beets-Tan, J.M. Borras, K. Haustermans, P. Maingon, J. Overgaard, L. Pahlman, P. Quirke, H.J. Schmoll, D. Sebag-Montefiore, I. Taylor, E. Van Cutsem, C. Van de Velde, N. Cellini, P. Latini, and C. Scientific (2009) Multidisciplinary rectal cancer management: 2nd European rectal cancer consensus conference (EURECA-CC2). Radiother Oncol 92(2). https://https://doi.org/10.1016/j.radonc.2009.06.027

Rodel, C., T. Liersch, H. Becker, R. Fietkau, W. Hohenberger, T. Hothorn, U. Graeven, D. Arnold, M. Lang-Welzenbach, H.R. Raab, H. Sulberg, C. Wittekind, S. Potapov, L. Staib, C. Hess, K. Weigang-Kohler, G.G. Grabenbauer, H. Hoffmanns, F. Lindemann, A. Schlenska-Lange, G. Folprecht, R. Sauer, and G. German Rectal Cancer Study (2012) Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol 13(7). https://https://doi.org/10.1016/S1470-2045(12)70187-0

Van Gijn, W., C.A. Marijnen, I.D. Nagtegaal, E.M. Kranenbarg, H. Putter, T. Wiggers, H.J. Rutten, L. Pahlman, B. Glimelius, C.J. van de Velde, and G. Dutch Colorectal Cancer (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12(6). https://https://doi.org/10.1016/S1470-2045(11)70097-3

Valentini, V., R.G. van Stiphout, G. Lammering, M.A. Gambacorta, M.C. Barba, M. Bebenek, F. Bonnetain, J.F. Bosset, K. Bujko, L. Cionini, J.P. Gerard, C. Rodel, A. Sainato, R. Sauer, B.D. Minsky, L. Collette, and P. Lambin (2011) Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol 29(23). https://https://doi.org/10.1200/JCO.2010.33.1595

Hong, Y.S., B.H. Nam, K.P. Kim, J.E. Kim, S.J. Park, Y.S. Park, J.O. Park, S.Y. Kim, T.Y. Kim, J.H. Kim, J.B. Ahn, S.B. Lim, C.S. Yu, J.C. Kim, S.H. Yun, J.H. Kim, J.H. Park, H.C. Park, K.H. Jung, and T.W. Kim (2014) Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial. Lancet Oncol 15(11). https://https://doi.org/10.1016/S1470-2045(14)70377-8

Polanco, P.M., A.A. Mokdad, H. Zhu, M.A. Choti, and S. Huerta (2018) Association of adjuvant chemotherapy with overall survival in patients with rectal cancer and pathologic complete response following neoadjuvant chemotherapy and resection. JAMA Oncol 4(7). https://https://doi.org/10.1001/jamaoncol.2018.0231

Maas., M., P.J. Nelemans., V. Valentini., C.H. Crane., C. Capirci., and C. Rodel. (2015) Adjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection: a pooled analysis of 3,313 patients - PubMed. International journal of cancer 137(1). https://https://doi.org/10.1002/ijc.29355

Sun, Y., H. Lin, X. Lu, Y. Huang, Z. Xu, S. Huang, X. Wang, and P. Chi (2017) A nomogram to predict distant metastasis after neoadjuvant chemoradiotherapy and radical surgery in patients with locally advanced rectal cancer. J Surg Oncol 115(4). https://https://doi.org/10.1002/jso.24522

Merkel, S., K. Weber, V. Schellerer, J. Gohl, R. Fietkau, A. Agaimy, W. Hohenberger, and P. Hermanek (2014) Prognostic subdivision of ypT3 rectal tumours according to extension beyond the muscularis propria. Br J Surg 101(5). https://https://doi.org/10.1002/bjs.9419

Kim, W.R., Y.D. Han, and B.S. Min (2018) C-reactive protein level predicts survival outcomes in rectal cancer patients undergoing total mesorectal excision after preoperative chemoradiation therapy. Ann Surg Oncol 25(13). https://https://doi.org/10.1245/s10434-018-6828-4

Fokas, E., T. Liersch, R. Fietkau, W. Hohenberger, T. Beissbarth, C. Hess, H. Becker, M. Ghadimi, K. Mrak, S. Merkel, H.R. Raab, R. Sauer, C. Wittekind, and C. Rodel (2014) Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial. J Clin Oncol 32(15). https://https://doi.org/10.1200/JCO.2013.54.3769

Conroy, T., J.F. Bosset, P.L. Etienne, E. Rio, E. Francois, N. Mesgouez-Nebout, V. Vendrely, X. Artignan, O. Bouche, D. Gargot, V. Boige, N. Bonichon-Lamichhane, C. Louvet, C. Morand, C. de la Fouchardiere, N. Lamfichekh, B. Juzyna, C. Jouffroy-Zeller, E. Rullier, F. Marchal, S. Gourgou, F. Castan, C. Borg, G. Unicancer Gastrointestinal, and G. Partenariat de Recherche en Oncologie Digestive (2021) Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 22(5). https://https://doi.org/10.1016/S1470-2045(21)00079-6

Bahadoer, R.R., E.A. Dijkstra, B. van Etten, C.A.M. Marijnen, H. Putter, E.M. Kranenbarg, A.G.H. Roodvoets, I.D. Nagtegaal, R.G.H. Beets-Tan, L.K. Blomqvist, T. Fokstuen, A.J. Ten Tije, J. Capdevila, M.P. Hendriks, I. Edhemovic, A. Cervantes, P.J. Nilsson, B. Glimelius, C.J.H. van de Velde, G.A.P. Hospers, and R.c. investigators (2021) Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol 22(1). https://https://doi.org/10.1016/S1470-2045(20)30555-6

Jin, J., Y. Tang, C. Hu, L.M. Jiang, J. Jiang, N. Li, W.Y. Liu, S.L. Chen, S. Li, N.N. Lu, Y. Cai, Y.H. Li, Y. Zhu, G.H. Cheng, H.Y. Zhang, X. Wang, S.Y. Zhu, J. Wang, G.F. Li, J.L. Yang, K. Zhang, Y. Chi, L. Yang, H.T. Zhou, A.P. Zhou, S.M. Zou, H. Fang, S.L. Wang, H.Z. Zhang, X.S. Wang, L.C. Wei, W.L. Wang, S.X. Liu, Y.H. Gao, and Y.X. Li (2022) Multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR). J Clin Oncol 40(15). https://https://doi.org/10.1200/JCO.21.01667

Hatt, M., F. Tixier, D. Visvikis, and C. Cheze Le Rest (2017) Radiomics in PET/CT: more than meets the eye? J Nucl Med 58(3). https://https://doi.org/10.2967/jnumed.116.184655

Kuo, M.D. and N. Jamshidi (2014) Behind the numbers: decoding molecular phenotypes with radiogenomics--guiding principles and technical considerations. Radiology 270(2). https://https://doi.org/10.1148/radiol.13132195

Gevaert, O., J. Xu, C.D. Hoang, A.N. Leung, Y. Xu, A. Quon, D.L. Rubin, S. Napel, and S.K. Plevritis (2012) Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results. Radiology 264(2). https://https://doi.org/10.1148/radiol.12111607

Cui, Y., G. Wang, J. Ren, L. Hou, D. Li, Q. Wen, Y. Xi, and X. Yang (2022) Radiomics features at multiparametric MRI predict disease-free survival in patients with locally advanced rectal cancer. Acad Radiol 29(8). https://https://doi.org/10.1016/j.acra.2021.11.024

Wang, F., B.F. Tan, S.S. Poh, T.R. Siow, F. Lim, C.S.P. Yip, M.L.C. Wang, W. Nei, and H.Q. Tan (2022) Predicting outcomes for locally advanced rectal cancer treated with neoadjuvant chemoradiation with CT-based radiomics. Sci Rep 12(1). https://https://doi.org/10.1038/s41598-022-10175-2

Tibermacine, H., P. Rouanet, M. Sbarra, R. Forghani, C. Reinhold, S. Nougaret, and G.S. Group (2021) Radiomics modelling in rectal cancer to predict disease-free survival: evaluation of different approaches. Br J Surg 108(10). https://https://doi.org/10.1093/bjs/znab191

Cui, Y., W. Yang, J. Ren, D. Li, X. Du, J. Zhang, and X. Yang (2021) Prognostic value of multiparametric MRI-based radiomics model: potential role for chemotherapeutic benefits in locally advanced rectal cancer. Radiother Oncol 154. https://https://doi.org/10.1016/j.radonc.2020.09.039

Li, M., Y.Z. Zhu, Y.C. Zhang, Y.F. Yue, H.P. Yu, and B. Song (2020) Radiomics of rectal cancer for predicting distant metastasis and overall survival. World J Gastroenterol 26(33). https://https://doi.org/10.3748/wjg.v26.i33.5008

Wen, L., J. Liu, P. Hu, F. Bi, S. Liu, L. Jian, S. Zhu, S. Nie, F. Cao, Q. Lu, X. Yu, and K. Liu (2023) MRI-based radiomic models outperform radiologists in predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Acad Radiol 30 Suppl 1. https://https://doi.org/10.1016/j.acra.2022.12.037

Jalil, O., A. Afaq, B. Ganeshan, U.B. Patel, D. Boone, R. Endozo, A. Groves, B. Sizer, and T. Arulampalam (2017) Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long-term survival in locally advanced rectal cancer treated by chemoradiotherapy. Colorectal Dis 19(4). https://https://doi.org/10.1111/codi.13496

Lovinfosse, P., M. Polus, D. Van Daele, P. Martinive, F. Daenen, M. Hatt, D. Visvikis, B. Koopmansch, F. Lambert, C. Coimbra, L. Seidel, A. Albert, P. Delvenne, and R. Hustinx (2018) FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. Eur J Nucl Med Mol Imaging 45(3). https://https://doi.org/10.1007/s00259-017-3855-5

Stollfuss, J.C., K. Becker, A. Sendler, S. Seidl, M. Settles, F. Auer, A. Beer, E.J. Rummeny, and K. Woertler (2006) Rectal carcinoma: high-spatial-resolution MR imaging and T2 quantification in rectal cancer specimens. Radiology 241(1). https://https://doi.org/10.1148/radiol.2411050942

Treiber, J.M., N.S. White, T.C. Steed, H. Bartsch, D. Holland, N. Farid, C.R. McDonald, B.S. Carter, A.M. Dale, and C.C. Chen (2016) Characterization and correction of geometric distortions in 814 diffusion weighted images. PLoS One 11(3). https://https://doi.org/10.1371/journal.pone.0152472

Tao, R., P.T. Fletcher, S. Gerber, and R.T. Whitaker (2009) A variational image-based approach to the correction of susceptibility artifacts in the alignment of diffusion weighted and structural MRI. Inf Process Med Imaging 21. https://https://doi.org/10.1007/978-3-642-02498-6_55

Liu, Z., X. Meng, H. Zhang, Z. Li, J. Liu, K. Sun, Y. Meng, W. Dai, P. Xie, Y. Ding, M. Wang, G. Cai, and J. Tian (2020) Predicting distant metastasis and chemotherapy benefit in locally advanced rectal cancer. Nat Commun 11(1). https://https://doi.org/10.1038/s41467-020-18162-9

Zhao, Y., F. Huang, S. Liu, L. Jian, X. Xia, H. Lin, and J. Liu (2023) Prediction of therapeutic response of unresectable hepatocellular carcinoma to hepatic arterial infusion chemotherapy based on pretherapeutic MRI radiomics and Albumin-Bilirubin score. J Cancer Res Clin Oncol 149(8). https://https://doi.org/10.1007/s00432-022-04467-3

Xie, K., C. Cui, X. Li, Y. Yuan, Z. Wang, and L. Zeng (2024) MRI-based clinical-imaging-radiomics nomogram model for discriminating between benign and malignant solid pulmonary nodules or masses. Acad Radiol 31(10). https://https://doi.org/10.1016/j.acra.2024.03.042

Lin, Y., Y. Gao, and T. Weng (2024) Construction and validation of a MRI‑based radiomic nomogram to predict overall survival in patients with local advanced cervical cancer: a multicenter study. Acad Radiol 31(11). https://https://doi.org/10.1016/j.acra.2024.05.003